With over 1 million patients tested, we can provide insights into observed prevalence rates and can inform future therapy development
By identifying where testing is taking place, our sponsors can improve allocation of clinical trial sites or commercial resources
Sponsors can better partner with health systems and major centers by sharing insights on genetic testing trends, treatment patterns, and more
Custom analysis allows for deeper understanding of correlations between phenotype and genotype and the spectrum of clinical presentations
Promotions can be targeted to certain clinicians, centers, or geographical areas
Published program research can be used to develop custom CME or educational programs for clinicians
Our high-quality, next-generation sequencing (NGS)-based diagnostic testing offers research opportunities using whole exome or whole genome sequencing. To learn more, email us at email@example.com.
Invitae takes patient privacy very seriously and will never share personal, identifiable information with the sponsor unless a patient specifically authorizes us to do so. For more information on how we protect privacy, please visit our privacy page.
Estimate your out-of-pocket cost for Invitae tests related to a personal or family history of breast, ovarian, colorectal, or uterine cancer.
The amount shown above is an estimate of your out-of-pocket cost based upon the information you entered about your health insurance coverage. It is not a confirmation that the test has been authorized by your insurance provider. Your final cost may vary based upon your health plan design, deductible, co-insurance, and out-of-pocket limits. Learn More >
As part of Invitae’s dedication to making high-quality genetic testing affordable and accessible, we also offer a patient pre-pay option of $250. Learn More >
We could not determine an out-of-pocket estimate. Please contact us for assistance.